Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.
- Family Elder
- Posts: 2903
- Joined: Wed Oct 14, 2009 2:00 pm
Novartis has been notified of a third case of progressive multifocal leukoencephalopathy (PML) in a patient with relapsing multiple sclerosis (MS) treated with Gilenya... Read More - http://www.ms-uk.org/gilenya
MS-UK - http://www.ms-uk.org/